MAZENCE INC.

City:

Daejeon

Country:

South Korea

Published Applications:

Last publication date:

2013-11-14

Patent Grants:

Last grant date:

2013-03-26

Top Inventors for applications by MAZENCE INC.

These are the the leading inventors for applications assigned to MAZENCE INC.:

Myung-Gyu Park 3 Gyeonggi-do, South Korea
Taehwan Kwak 3 Gyeonggi-do, South Korea
Sang Woo Yoo 2 Seoul, South Korea
Sang-Ku YOO 2 Gwacheon-si, South Korea

Myung-Gyu Park 2 Yongin-si, South Korea
Taehwan KWAK 2 Yongin-si, South Korea
In Geun JO 1 Cheonan-si, South Korea
Sang-Ku Yoo 1 Gwacheon-shi,, South Korea

Ku Suk KANG 1 Siheung-si, South Korea
Kyoung Hoon Jung 1 Gyeonggi-do, South Korea
Taehwan Kwak 1 Yongin-shi, South Korea
Ku Suk Kang 1 Siheung-shi, South Korea

Kyoung Hoon Jung 1 Anyang-si, South Korea

Recent patent applications by MAZENCE INC.

MAZENCE INC. based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-11-14

US20130302422A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF KIDNEY DISEASES

#2 | 2011-01-27

US20110020448A1

Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GLAUCOMA

#3 | 2011-01-06

US20110002995A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE

#4 | 2010-12-09

US20100310657A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF KIDNEY DISEASES

#5 | 2010-06-03 ✅ Patent 8,404,869 granted on 2013-03-26

US20100137422A1

Chemistry; metallurgy

Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

#6 | 2010-03-11

US20100062065A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM

#7 | 2009-05-14

US20090124680A1

Human necessities

USE OF PRODRUG COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR MANUFACTURE OF MEDICAMENT FOR TREATMENT OR PREVENTION OF DISEASES INVOLVING METABOLIC SYNDROME

AssigneeID:

45289 ⎘